Advertisement

MHV Neuropathogenesis: The Study of Chimeric S Genes and Mutations in the Hypervariable Region

  • Joanna J. Phillips
  • Susan R. Weiss
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 494)

Abstract

Mouse hepatitis virus (MHV) is studied as a model system for both acute and chronic virus-induced neurologic disease. Infection of susceptible mice with MHV results in a potentially fatal acute encephalomyelitis, and survivors of this acute disease often go on to develop a chronic demyelinating disease. Using targeted recombination we have demonstrated that the MHV spike (S) glycoprotein is a major determinant of the severity of the acute disease (Phillips et al., 1999). Isogenic recombinant viruses differing exclusively in the spike gene were found to differ dramatically in their neurovirulence. Recombinants containing the spike of the highly neurovirulent MHV-4 virus were highly neurovirulent while recombinants containing the spike of the mildly neurovirulent MHV-A59 virus exhibited a similarly mild degree of neurovirulence.

Keywords

Recombinant Virus Hypervariable Region Spike Gene Efficient Replication Mouse Hepatitis Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Dalziel, R. G., P. W. Lampert, P. J. Talbot, and M. J. Buchmeier. 1986. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:463–471.PubMedGoogle Scholar
  2. Fazakerley, J. K., S. E. Parker, F. Bloom, and M. J. Buchmeier. 1992. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virol. 187:178–188.CrossRefGoogle Scholar
  3. Fleming, J. O., M. D. Trousdale, F. A. K. El-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine Coronavirus JHM seleced with monoclonal antibodies. J. Virol. 58:869–875.PubMedGoogle Scholar
  4. Kuo, L., G.-J. Godeke, M. J. B. Raamsman, P. S. Masters, and P. J. M. Rottier. 2000. Retargeting of Coronavirus by substitution of the spike glycoprotein ectodomain: Crossing the host cell species barrier. J. Virol. 74:1393–1406.PubMedCrossRefGoogle Scholar
  5. Parker, S. E., T. M. Gallagher, and M. J. Buchmeier. 1989. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173:664–673.PubMedCrossRefGoogle Scholar
  6. Phillips, J. J., M. M. Chua, E. Lavi, and S. R Weiss. 1999. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine Coronavirus spike protein is a major determinant of neurovirulence. J. Virol. 73:7752–7760.PubMedGoogle Scholar
  7. Wege, H., J. Winter, and R. Meyermann. 1988. The peplomer protein E2 of Coronavirus JHM as a determinant of neurovirulence: Definition of critical epitopes by variant analysis. J. Gen. Virol. 69:87–98.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Joanna J. Phillips
    • 1
  • Susan R. Weiss
    • 1
  1. 1.Department of MicrobiologyUniversity of Pennsylvania School of MedicinePhiladelphiaUSA

Personalised recommendations